Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Cash Flow Breakdown

Cash flow breakdown shows where EMERGENT BIOSOLUTIONS INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $170.60M came in.
  • Fiscal year ended 2025-12-31: from investing, $69.40M came in.
  • Fiscal year ended 2025-12-31: from financing, $136.60M went out.
  • Fiscal year ended 2025-12-31: change in cash, $103.50M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31$170.60M$69.40M-$24.90M-$3.80M$2.20M$0.00-$1.40M$0.00-$108.70M*$103.50M
2024-12-31$58.70M$125.20M$0.00$0.00$0.00-$284.20M-$1.20M$0.00$95.40M*-$6.10M
2023-12-31-$206.30M$212.30M$0.00$0.00$0.00-$398.80M-$2.50M$8.40M-$142.80M*-$530.90M
2022-12-31-$34.10M-$381.30M-$82.10M$0.00$0.00-$5.90M$0.00$569.20M*$66.30M
2021-12-31$320.20M-$224.10M-$106.00M$0.00$0.00-$13.80M$0.00-$21.20M*-$45.20M
2020-12-31$536.90M-$151.90M$0.00$450.00M-$373.00M-$13.80M$27.60M-$21.30M*$453.50M
2019-12-31$188.00M-$96.90M$0.00$0.00-$105.00M-$7.40M$8.20M$68.30M*$55.60M
2018-12-31$41.80M-$897.20M-$100.00K-$2.80M$798.00M-$6.60M$15.90M*$0.00-$66.90M
2017-12-31$208.10M-$249.90M-$33.10M$0.00$0.00-$4.30M$19.30M$0.00-$33.30M*-$93.20M
2016-12-31$54.60M-$76.20M$0.00$0.00$0.00-$1.10M$17.10M$10.60M-$46.40M*-$41.30M
2015-12-31$42.52M-$45.46M-$100.00K$0.00$2.00M$1.94M$25.96M$11.28M-$5.69M*$32.30M
2014-12-31$112.32M-$210.05M-$200.00K-$62.00M$1.00M$14.08M$5.99M$240.01M*$101.16M
2013-12-31$96.97M-$67.89M-$213.00K-$62.77M$6.85M$3.10M$61.65M*$37.67M
2012-12-31$39.64M-$40.11M-$5.91M-$10.23M$761.00K$1.59M$12.02M*-$2.23M
2011-12-31$12.19M-$53.96M$0.00-$15.49M$10.03M$4.61M$17.52M*-$25.12M
2010-12-31$98.02M-$23.46M$0.00-$33.29M$7.24M$2.61M$15.00M*$66.09M
2009-12-31$29.87M-$33.29M$4.46M$1.85M$8.53M*$11.45M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtCommercial paperStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30$56.10M*-$52.30M*-$9.00M*-$400.00K*-$15.00M*
2026-03-31-$33.80M-$2.40M-$9.00M-$2.80M$400.00K-$47.60M
2025-12-31$77.70M*-$3.90M*-$9.10M*$0.00*-$400.00K*-$1.00M*-$103.40M*
2025-09-30-$2.30M*-$3.40M*-$8.90M*$0.00*-$300.00K*-$6.70M*
2025-06-30$106.40M*$17.20M*-$6.90M*$0.00*-$200.00K*$700.00K*
2025-03-31-$11.20M$59.50M$0.00$0.00-$500.00K$0.00$47.20M
2024-12-31-$79.90M*$28.60M*$0.00*$0.00*-$300.00K*$0.00*$800.00K*
2024-09-30$153.70M*$112.00M*$0.00*-$222.70M*-$300.00K*$0.00*$42.70M*
2024-06-30$47.50M*-$4.60M*-$56.50M*-$200.00K*$5.80M*
2024-03-31-$62.60M-$10.80M-$5.00M-$400.00K$46.10M*-$32.70M
2023-12-31$32.10M*-$11.40M*$0.00*-$12.00M*-$100.00K*$200.00K*$16.60M*
2023-09-30$60.00M*-$18.90M*$0.00*-$39.00M*-$100.00K*$0.00*-$3.90M*
2023-06-30-$114.40M*$257.70M*$0.00*-$347.80M*-$200.00K*-$138.90M*
2023-03-31-$184.00M-$15.10M$0.00$0.00-$2.10M-$8.40M*-$209.80M
2022-12-31$92.80M*-$45.40M*-$200.00K*$0.00*-$200.00K*$0.00*$353.50M*
2022-09-30-$74.00M*-$271.60M*$0.00*$0.00*-$300.00K*$0.00*$229.60M*
2022-06-30-$15.60M*-$32.10M*-$24.40M*-$400.00K*-$5.90M*
2022-03-31-$37.30M-$32.20M-$57.50M-$5.00M-$8.00M*-$140.30M
2021-12-31$328.10M*-$45.80M*-$106.00M*$0.00*$0.00*-$300.00K*-$3.70M*
2021-09-30$16.70M*-$55.20M*$0.00*$0.00*-$500.00K*-$4.50M*
2021-06-30-$29.70M*-$67.00M*$0.00*$0.00*-$800.00K*-$3.00M*
2021-03-31$5.10M-$56.10M$0.00$0.00-$12.20M-$10.00M*-$73.50M
2020-12-31$246.00M*-$36.90M*$0.00*$0.00*-$1.00M*$1.00M*-$2.30M*
2020-09-30$105.20M*-$45.70M*-$353.00M*-$1.10M*$3.50M*$437.70M*
2020-06-30$127.90M*-$45.10M*$0.00*-$6.10M*$14.00M*-$3.20M*
2020-03-31$57.80M-$24.20M-$20.00M*-$5.60M$9.10M-$3.50M*$13.70M
2019-12-31$122.10M*-$36.10M*$0.00*$0.00*-$10.00M*-$800.00K*$2.50M*-$49.60M*
2019-09-30-$3.10M*-$15.30M*$0.00*-$15.00M*-$300.00K*$1.10M*-$5.50M*
2019-06-30-$35.80M*-$24.10M*$0.00*$100.00M*-$300.00K*$3.70M*
2019-03-31$104.80M-$21.40M$0.00-$50.00M*-$6.00M$900.00K-$3.30M*$25.00M
2018-12-31-$165.80M*-$848.50M*$0.00*-$300.00K*$4.50M*$781.70M*-$227.97M*
2018-09-30$174.00M*-$26.10M*$0.00*$0.00*-$300.00K*$2.90M*-$900.00K*$149.12M*
2018-06-30$34.60M*-$11.00M*$0.00*$0.00*-$100.00K*$3.80M*-$500.00K*$26.63M*
2018-03-31-$1.00M-$11.60M-$100.00K$0.00*-$5.90M$4.70M-$800.00K*-$14.70M
2017-12-31$77.49M*-$207.52M*-$33.02M*-$116.00K*$8.50M*$0.00*-$162.68M*
2017-09-30$34.94M*-$12.78M*$0.00*-$125.00K*$6.19M*$0.00*-$2.81M*$25.36M*
2017-06-30$54.00M*-$9.30M*-$2.00K*-$44.00K*$1.65M*$0.00*-$837.00K*$45.46M*
2017-03-31$41.67M-$20.30M-$81.00K-$4.01M$2.96M$0.00-$21.57M*-$1.34M
2016-12-31-$12.65M*-$19.96M*$0.00*$0.00*$3.49M*$2.12M*-$225.00K*-$27.44M*
2016-09-30$27.08M*-$17.00M*$0.00*-$98.00K*$457.00K*$383.00K*-$45.26M*-$34.46M*
2016-06-30-$6.49M*-$21.03M*$0.00*-$115.00K*$10.93M*$4.66M*$4.27M*-$7.62M*
2016-03-31$42.17M-$18.21M$0.00-$4.38M$3.60M$5.79M-$752.00K*$28.22M
2015-12-31$1.13M*-$11.83M*$0.00*$0.00*$10.06M*$3.28M*$1.58M*$4.08M*
2015-09-30$104.76M*-$13.95M*$0.00*$2.74M*$761.00K*$93.88M*
2015-06-30$2.50M*-$10.60M*$0.00*$6.82M*$1.83M*-$1.67M*
2015-03-31-$65.87M-$9.08M$0.00$6.34M$5.41M-$762.00K*-$63.98M
2014-12-31$51.82M*-$17.26M*$0.00*$3.42M*$421.00K*$38.25M*
2014-09-30$78.92M*-$5.22M*$0.00*$687.00K*$387.00K*$74.12M*
2014-06-30$10.82M*-$4.81M*$0.00*$1.83M*$609.00K*$7.92M*
2014-03-31-$29.25M-$182.76M-$62.00M$8.14M$4.57M$242.17M*-$19.12M
2013-12-31$8.64M*-$9.35M*-$213.00K*-$59.42M*$4.34M*$1.15M*$61.65M*$6.78M*
2013-09-30$60.13M*-$44.42M*-$1.12M*$1.57M*$192.00K*$16.32M*
2013-06-30$32.83M*-$6.44M*-$1.12M*$429.00K*$149.00K*$26.00M*
2013-03-31-$4.63M-$7.68M-$1.12M$504.00K$1.61M-$11.43M
2012-12-31-$39.02M*-$12.90M*-$4.45M*-$841.00K*$266.00K*$106.00K*-$56.23M*
2012-09-30$46.48M*-$10.02M*-$716.00K*$94.00K*$175.00K*$36.06M*
2012-06-30$18.34M*-$8.59M*-$467.00K*$159.00K*$189.00K*$1.79M*$11.42M*
2012-03-31$13.84M-$8.60M-$8.20M*$242.00K$1.12M$6.52M
2011-12-31$36.93M*-$18.34M*$0.00*-$563.00K*$1.19M*$3.11M*-$3.78M*$18.55M*
2011-09-30$4.66M*-$15.81M*-$6.81M*$141.00K*-$284.00K*$21.30M*$3.25M*
2011-06-30-$6.68M*-$7.07M*$4.50M*$1.75M*-$7.28M*-$14.83M*
2011-03-31-$22.72M-$12.74M$4.20M$39.00K-$842.00K*-$32.09M
2010-12-31$22.66M*-$9.41M*$3.18M*$1.53M*-$839.00K*$17.79M*
2010-09-30$54.17M*-$5.41M*$1.27M*$368.00K*$49.04M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45